The prospect of Brexit is causing concern to the pharmaceutical sector, as borne out by the report from an experts' meeting that took place on 8 March last. According to this report, many different authorisation documents on the market are still not ready for functioning when the United Kingdom leaves the Union.
The technical meeting brought together around 80 experts from the EU27 and the European Economic Area. The aim of this event, arranged by the European Commission, was to provide...